This clinical trial aims to evaluate the effectiveness of lymphatic microsurgical treatments in reducing limb volume in female patients with breast cancer-related lymphedema (BCRL). The study focuses on three treatments: Lymphovenous Anastomosis (LVA), Vascularized Lymph Node Transfer (VLNT), and Complex Decongestive Therapy (CDT). The main questions it aims to answer are: * Can LVA, VLNT, or their combination significantly reduce limb volume in patients with BCRL? * How does the effectiveness of these surgical interventions compare to CDT alone? Researchers will compare patients who undergo LVA, VLNT, or a combination of both to those receiving only CDT to determine the effectiveness of surgical interventions in reducing lymphedema symptoms. Participants will: * Undergo pre- and post-operative limb volume measurements. * Receive either LVA, VLNT, or combined LVA and VLNT surgery, or continue CDT alone. * Be monitored for one year to assess changes in limb volume and quality of life.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Relative interlimb difference
Timeframe: Before intervention and one year post-intervention